1
|
Moscarello T, Higgs E, Pollard E, Monroe M, Nguyen TMP, Campion M, Reuter CM. Assessing and attending to psychosocial concerns in genetic counseling: Proposing the BATHE method. J Genet Couns 2025; 34:e1998. [PMID: 39535335 DOI: 10.1002/jgc4.1998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Revised: 10/22/2024] [Accepted: 10/23/2024] [Indexed: 11/16/2024]
Abstract
The process of identifying and responding to patients' social, emotional, and psychological concerns is a required skill for training and practicing genetic counselors. Patients' health outcomes are improved when genetic counselors attend to these "psychosocial" concerns. Still, the process of eliciting, assessing, and attending to patients' psychosocial concerns in the genetic counseling setting is not well defined in the literature nor is it performed consistently. Tools that do exist are often questionnaire-based, designed for research use, or occur outside of a genetic counseling appointment. Here we describe the complexities of defining "psychosocial assessment" in genetic counseling, its impact on patient outcomes, and summarize existing tools for psychosocial assessment. We identify a need for evidenced-based, verbally-administered psychosocial assessment tools in genetic counseling and explore the value of adapting an existing tool from primary care (the BATHE method) to genetic counseling. The BATHE method is a semi-structured psychosocial assessment tool that can be performed quickly within a patient appointment to gather context, emotional impact, the patient's primary concern, and coping strategies. Through our professional experiences we believe it is a beneficial psychosocial assessment tool as perceived by both patients and genetic counselors. Further work is needed to determine if the BATHE method could fill a gap in how genetic counselors conduct a psychosocial assessment.
Collapse
Affiliation(s)
- Tia Moscarello
- Stanford Center for Inherited Cardiovascular Disease, Stanford Health Care, Stanford, California, USA
| | - Emily Higgs
- Cardiovascular Genetics Program, University of California, San Francisco, California, USA
| | - Elizabeth Pollard
- Department of Genetics, Stanford University School of Medicine, Stanford, California, USA
| | - Mattie Monroe
- Department of Genetics, Stanford University School of Medicine, Stanford, California, USA
| | - Thuy-Mi P Nguyen
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
| | - MaryAnn Campion
- Department of Genetics, Stanford University School of Medicine, Stanford, California, USA
| | - Chloe M Reuter
- Stanford Center for Inherited Cardiovascular Disease, Stanford Health Care, Stanford, California, USA
- Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
| |
Collapse
|
2
|
Perry J, Bunnik E, Rietschel M, Bentzen HB, Ingvoldstad Malmgren C, Pawlak J, Chaumette B, Tammimies K, Bialy F, Bizzarri V, Borg I, Coviello D, Crepaz-Keay D, Ivanova E, McQuillin A, Mežinska S, Johansson Soller M, Suvisaari J, Watson M, Wirgenes K, Wynn SL, Degenhardt F, Schicktanz S. Unresolved ethical issues of genetic counseling and testing in clinical psychiatry. Psychiatr Genet 2025; 35:26-36. [PMID: 39945108 DOI: 10.1097/ypg.0000000000000385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/09/2025]
Abstract
OBJECTIVE This position article discusses current major ethical and social issues related to genetic counseling and testing in clinical psychiatry (PsyGCT). METHODS To address these complex issues in the context of clinical psychiatry relevant to PsyGCT, the interdisciplinary and pan-European expert Network EnGagE (Enhancing Psychiatric Genetic Counseling, Testing, and Training in Europe; CA17130) was established in 2018. We conducted an interdisciplinary, international workshop at which we identified gaps across European healthcare services and research in PsyGCT; the workshop output was summarized and systematized for this position article. RESULTS Four main unresolved ethical topics were identified as most relevant for the implementation of PsyGCT: (1) the problematic dualism between somatic and psychiatric disorders, (2) the impact of genetic testing on stigma, (3) fulfilling professional responsibilities, and (4) ethical issues in public health services. We provide basic recommendations to inform psychiatrists and other healthcare professionals involved in the clinical implementation of PsyGCT and conclude by pointing to avenues of future ethics research in PsyGCT. CONCLUSION This article draws attention to a set of unresolved ethical issues relevant for mental health professionals, professionals within clinical genetics, patients and their family members, and society as a whole and stresses the need for more interdisciplinary exchange to define standards in psychiatric counseling as well as in public communication. The use of PsyGCT may, in the future, expand and include genetic testing for additional psychiatric diagnoses. We advocate the development of pan-European ethical standards addressing the four identified areas of ethical-practical relevance in PsyGCT.
Collapse
Affiliation(s)
- Julia Perry
- Department of Medical Ethics and History of Medicine, University Medical Center Göttingen, Göttingen, Germany
| | - Eline Bunnik
- Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
| | - Marcella Rietschel
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany
| | - Heidi Beate Bentzen
- Centre for Medical Ethics, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Charlotta Ingvoldstad Malmgren
- Center for Research Ethics and Bioethics, CRB, Department for Public Health and Caring Sciences, Uppsala University, Uppsala
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
| | - Joanna Pawlak
- Department of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, Poznań, Poland
| | - Boris Chaumette
- Université Paris Cité, Institut Pasteur (Human Genetics and Cognitive Functions, CNRS UMR3571), Institute of Psychiatry and Neuroscience of Paris (INSERM U1266), GHU Paris Psychiatrie et Neurosciences, Paris, France
| | - Kristiina Tammimies
- Department of Women's and Children's Health, Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND), Karolinska Institutet, Stockholm
- Astrid Lindgren's Children Hospital, Karolinska University Hospital, Stockholm, Sweden
| | - Filip Bialy
- Collegium Polonicum, Adam Mickiewicz University Poznań, Poznań, Poland
- Department of Politics, University of Manchester, Manchester, UK
| | - Virginia Bizzarri
- Department of Mental Health and Pathological Addictions, Neuropsychiatry of Childhood and Adolescence, ASL3, Genova, Italy
| | - Isabella Borg
- Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida
- Medical Genetics Unit, Department of Pathology, Mater Dei Hospital, L-Imsida
- Centre for Molecular Medicine and Biobanking, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
| | - Domenico Coviello
- Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, Genova, Italy
| | | | - Eliza Ivanova
- Department of General, Experimental, Developmental, and Health Psychology, Faculty of Philosophy, Sofia University, Sofia, Bulgaria
| | | | - Signe Mežinska
- Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia
| | - Maria Johansson Soller
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- Department of Clinical Genetics and Genomics, Medical Diagnostics, Karolinska University Hospital, Stockholm, Sweden
| | - Jaana Suvisaari
- Department of Healthcare and Social Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
| | - Melanie Watson
- Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Katrine Wirgenes
- Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
| | - Sarah L Wynn
- Unique, Rare Chromosome Disorder Support Group, Oxted, Surrey, UK
| | - Franziska Degenhardt
- Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Duisburg
- Institute of Human Genetics, University of Bonn, Bonn, Germany
| | - Silke Schicktanz
- Department of Medical Ethics and History of Medicine, University Medical Center Göttingen, Göttingen, Germany
| |
Collapse
|
3
|
Dane A, Berkman J, DeBortoli E, Wallingford CK, Yanes T, McInerney‐Leo A. Narrative therapy and family therapy in genetic counseling: A scoping review. J Genet Couns 2025; 34:e1938. [PMID: 38899485 PMCID: PMC11907181 DOI: 10.1002/jgc4.1938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 06/02/2024] [Accepted: 06/03/2024] [Indexed: 06/21/2024]
Abstract
Genetic counseling facilitates psychological and social adaptation in clients and families. Two psychotherapeutic approaches, narrative and family therapy foster client adaptation to adverse situations and may enhance the genetic counseling process. This scoping review aimed to describe the applications of narrative therapy and family therapy in genetic counseling, and to document the actual and perceived value of these approaches in a genetic counseling setting. Nine original research articles and six commentary articles met the study inclusion criteria. Original articles reported on positive client attitudes when these approaches were applied to hereditary cancer and Huntington disease settings. Five studies applied either approach in group sessions, where safety was key to positive outcomes, including sharing lived experiences and coping strategies. Balanced utilization of structured and open elements in group sessions maximized a sense of control, while also allowing for opportunity to self-disclose. Narrative therapy interventions were time efficient and were reported to foster connection with others and shape a new adaptive narrative centered around strengths. Family therapy approaches, based on experiential family therapy, the intersystem model, object relations family therapy, and the social ecology model, required a greater time commitment, but promoted disclosure of complex feelings and diffused tension. Family therapy genogram tools were feasible in practice, easy to implement, and effective at identifying communication barriers. Commentary articles highlighted the alignment of both approaches with genetic counseling goals and their potential value in practice. Utilization of psychotherapeutic approaches can improve counselors' ability to shape sessions, enhance insight and optimize efficacy, and flexibility in moving between models can maximize impact. This review highlights the paucity of studies investigating the efficacy of these psychotherapeutic approaches in the genetic counseling context and the need for more outcomes-based research on the utilization of narrative or family therapy in genetic counseling practice.
Collapse
Affiliation(s)
- Aimee Dane
- Cardiology DepartmentPrince Charles HospitalBrisbaneQueenslandAustralia
| | - Jennifer Berkman
- Dermatology Research Centre, Frazer InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Emily DeBortoli
- Dermatology Research Centre, Frazer InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Courtney K. Wallingford
- Dermatology Research Centre, Frazer InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Tatiane Yanes
- Dermatology Research Centre, Frazer InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Aideen McInerney‐Leo
- Dermatology Research Centre, Frazer InstituteUniversity of QueenslandBrisbaneQueenslandAustralia
| |
Collapse
|
4
|
Fang J, Li LH, He MQ, Ji Y, Lu DY, Zhang LB, Yao JL. Mediating role of health literacy in the relationship between social isolation and psychological distress among pre-frail older adults. World J Psychiatry 2025; 15:100953. [PMID: 39831020 PMCID: PMC11684227 DOI: 10.5498/wjp.v15.i1.100953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2024] [Revised: 11/02/2024] [Accepted: 11/26/2024] [Indexed: 12/18/2024] Open
Abstract
BACKGROUND Frailty has become a significant public health issue. The recent increase in the number of frail older adults has led to increased attention being paid to psychological care services in communities. The social isolation of pre-frail older adults can impact their psychological distress. AIM To explore the mediating effect of health literacy between social isolation and psychological distress among communitydwelling older adults with pre-frailty. METHODS This descriptive cross-sectional study was conducted with 254 pre-frail older individuals aged 60 years and over. Social isolation, health literacy, and psychological distress were comprehensively measured using the Lubben Social Network Scale-6, 12-item Short-Form Health Literacy Questionnaire, and the Kessler Psychological Distress Scale-10. Data were evaluated using the SPSS 27.0 package program and the PROCESS macro tool. Descriptive statistical analyses, correlation analyses, and bootstrap mediation tests were used to assess associations between the variables. RESULTS The results showed that social isolation had an effect on health literacy among pre-frail older adults (β = 0.240, P < 0.001), social isolation impact on psychological distress pre-frail older adults (β = -0.415, P < 0.001); health literacy was identified effect on psychological distress among pre-frail older persons (β = -0.307, P < 0.001). Health literacy partially mediated the relationship between social isolation and psychological distress among community-dwelling older adults with pre-frailty, with a mediation effect of -0.074, accounting for 17.83% of the total effect. CONCLUSION Health literacy significantly affects the relationship between social isolation and psychological distress among pre-frail older adults. Apart from fostering social connections, improved health literacy measures should be considered.
Collapse
Affiliation(s)
- Juan Fang
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| | - Li-Hui Li
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| | - Ming-Qian He
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| | - Yue Ji
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| | - Dong-Yan Lu
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| | - Li-Bing Zhang
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| | - Jin-Lan Yao
- School of Medicine, Huzhou University, Huzhou 313000, Zhejiang Province, China
| |
Collapse
|
5
|
Nusbaum CLM, Wirth M, Obler D, Redlinger-Grosse K, Cirino AL. A qualitative exploration of interprofessional collaborative practice between genetic counselors and mental health providers. J Community Genet 2024; 15:103-117. [PMID: 38066351 PMCID: PMC11031548 DOI: 10.1007/s12687-023-00690-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2023] [Accepted: 11/22/2023] [Indexed: 04/20/2024] Open
Abstract
Genetic counselors (GCs) typically provide short-term counseling and assess patient needs, including the need for ongoing psychosocial support. While some patients may benefit from a referral to a mental health provider (MHP), previous research identified barriers to this process due to patient characteristics, the GC work environment, and MHP availability. Adoption of interprofessional collaborative practice (IPCP), a model where multiple healthcare professionals from diverse training disciplines collaborate to deliver patient care, may mitigate these barriers. Evidence suggests that IPCP both increases patient satisfaction and reduces healthcare spending. Anecdotal evidence suggests that GCs and MHPs may use IPCP in select institutions, but there is limited research examining these relationships. This study aims to characterize the benefits, barriers, and limitations of current IPCP practice between GCs and MHPs. Six semi-structured interviews with GCs and MHPs were completed and analyzed thematically. Four themes emerged: (1) mental health concerns in GC sessions and GC scope of practice; (2) establishing and maintaining IPCP between GCs and MHPs; (3) benefits, barriers, and limitations of IPCP; and (4) next steps to develop future IPCP. The findings suggest that there are varying approaches to IPCP that are influenced by perceptions of provider scope of practice. IPCP may mitigate some previously described referral barriers related to logistics, and the availability of trusted MHPs with knowledge of a GCs specialty, thereby improving patient and provider satisfaction.
Collapse
Affiliation(s)
- Claire Lily Martha Nusbaum
- Genetic Counseling Program, MGH Institute of Health Professions, Boston, MA, USA.
- Perinatal Associates of the Mid-Atlantic, Part of Pediatrix Medical Group, Rockville, MD, USA.
| | - Megan Wirth
- Department of Obstetrics & Gynecology, Dartmouth Health, Bedford, NH, USA
| | - Dita Obler
- Moving Beyond a Diagnosis Genetic Consultation and Counseling, Cambridge, MA, USA
| | - Krista Redlinger-Grosse
- Department of Genetics, Cell Biology, and Development, Institute of Human Genetics, University of Minnesota, Minneapolis, MN, USA
| | - Allison L Cirino
- Genetic Counseling Program, MGH Institute of Health Professions, Boston, MA, USA
| |
Collapse
|
6
|
Davies R, Price Tate R, Taverner NV. What next for "counseling" in genetic counseling training: A reflection on how CBT and ACT approaches can contribute to the genetic counseling toolkit. J Genet Couns 2024; 33:129-134. [PMID: 38342751 DOI: 10.1002/jgc4.1873] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Revised: 01/07/2024] [Accepted: 01/30/2024] [Indexed: 02/13/2024]
Abstract
Counseling techniques are an important component of genetic counseling training and are focused on the person-centered counseling philosophy. While this has a long tradition within the profession and underpins the empowerment goal, it should not limit consideration of the potential benefits of education on other psychotherapeutic approaches such as the cognitive philosophy. The goal of empowerment in genetic counseling requires patients to receive information in a way that is accessible to them and to make sense of it in relation to their own health, lifestyle, and family information. This assimilation of new information is a complex cognitive process, and yet it is one that genetic counselors do not routinely actively facilitate. Rather the counseling component of genetic counseling has traditionally focused on emotionally supporting the patient which is driven by the person-centered philosophy that is covered in genetic counseling training. This paper argues for the potential for adopting more cognitive approaches informed by cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT), as these short interventions can have wide impact, including engaging patients who do not want to discuss feelings, helping people to make sense of information (not just gain knowledge), and helping people to change the relationship they have with their thoughts. This paper advocates for an introduction to CBT and ACT to be incorporated into prequalification training and for more advanced training to be available to postqualification genetic counselors.
Collapse
Affiliation(s)
- Rachel Davies
- Faculty of Life Sciences and Education, University of South Wales, Newport, UK
| | | | | |
Collapse
|
7
|
Davies R, Price Tate R, Taverner NV. What next for "counseling" in genetic counseling training: A co-production workshop exploring how CBT and ACT approaches can contribute to the genetic counseling toolkit. J Genet Couns 2024; 33:124-128. [PMID: 38379347 DOI: 10.1002/jgc4.1868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Revised: 01/07/2024] [Accepted: 01/11/2024] [Indexed: 02/22/2024]
Abstract
Counseling techniques are an important part of genetic counseling, and teaching of the humanistic person-centered philosophy has been central to genetic counselor (GC) training. However, other psychotherapeutic approaches, especially cognitive approaches, may also be beneficial for the GC to have in their toolkit. This paper reports on a co-production workshop with newly qualified GCs where the potential for adopting more cognitive approaches informed by cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT) was explored. Attendees were taught about the approaches and the rationale for their use in genetic counseling and had a chance to discuss their reactions and ideas for application. The attendees saw great potential for the approaches within their practice, feeling that these short interventions can have a wide impact, including engaging patients who do not want to discuss feelings, helping people to make sense of information (not just gain knowledge), and helping people to change the relationship they have with their thoughts. They were able to identify when they already use some cognitive approaches in their practice, and to see how they could build on this to provide better patient care. The paper advocates for an introduction to CBT and ACT to be incorporated into pre-qualification training, and for more advanced training to be available to post-qualification GCs.
Collapse
Affiliation(s)
- Rachel Davies
- Faculty of Life Sciences and Education, University of South Wales, Newport, UK
| | | | | |
Collapse
|
8
|
Kohut K, Morton K, Turner L, Shepherd J, Fenerty V, Woods L, Grimmett C, Eccles DM, Foster C. Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience. FRONTIERS IN HEALTH SERVICES 2023; 3:1092816. [PMID: 37395995 PMCID: PMC10311450 DOI: 10.3389/frhs.2023.1092816] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Accepted: 04/26/2023] [Indexed: 07/04/2023]
Abstract
Background Patients with genetic cancer susceptibility are presented with complex management options involving difficult decisions, for example about genetic testing, treatment, screening and risk-reducing surgery/medications. This review sought to explore the experience of patients using decision support resources in this context, and the impact on decision-making outcomes. Methods Systematic review of quantitative, qualitative and mixed-methods studies involving adults with or without cancer who used a decision support resource pre- or post-genetic test for any cancer susceptibility. To gather a broad view of existing resources and gaps for development, digital or paper-based patient resources were included and not limited to decision aids. Narrative synthesis was used to summarise patient impact and experience. Results Thirty-six publications describing 27 resources were included. Heterogeneity of resources and outcome measurements highlighted the multiple modes of resource delivery and personal tailoring acceptable to and valued by patients. Impact on cognitive, emotional, and behavioural outcomes was mixed, but mainly positive. Findings suggested clear potential for quality patient-facing resources to be acceptable and useful. Conclusions Decision support resources about genetic cancer susceptibility are likely useful to support decision-making, but should be co-designed with patients according to evidence-based frameworks. More research is needed to study impact and outcomes, particularly in terms of longer term follow-up to identify whether patients follow through on decisions and whether any increased distress is transient. Innovative, streamlined resources are needed to scale up delivery of genetic cancer susceptibility testing for patients with cancer in mainstream oncology clinics. Tailored patient-facing decision aids should also be made available to patients identified as carriers of a pathogenic gene variant that increases future cancer risks, to complement traditional genetic counselling. Systematic Review Registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020220460, identifier: CRD42020220460.
Collapse
Affiliation(s)
- Kelly Kohut
- Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, United Kingdom
- Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom
| | - Kate Morton
- Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, United Kingdom
| | - Lesley Turner
- Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, United Kingdom
| | - Jonathan Shepherd
- Southampton Health Technology Assessments Centre, University of Southampton, Southampton, United Kingdom
| | - Vicky Fenerty
- Engagement Services, University of Southampton Library, University of Southampton, Southampton, United Kingdom
| | - Lois Woods
- Southampton Health Technology Assessments Centre, University of Southampton, Southampton, United Kingdom
| | - Chloe Grimmett
- Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, United Kingdom
| | - Diana M. Eccles
- Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Claire Foster
- Centre for Psychosocial Research in Cancer: CentRIC, School of Health Sciences, University of Southampton, Southampton, United Kingdom
| |
Collapse
|
9
|
Paneque M, Guimarães L, Bengoa J, Pasalodos S, Cordier C, Esteban I, Lemos C, Moldovan R, Serra-Juhé C. An European overview of genetic counselling supervision provision. Eur J Med Genet 2023; 66:104710. [PMID: 36731744 DOI: 10.1016/j.ejmg.2023.104710] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 12/28/2022] [Accepted: 01/22/2023] [Indexed: 02/03/2023]
Abstract
Genetic testing is becoming more commonplace in general and specialist health care, and should always be accompanied by genetic counselling, according to legislation in many European countries and recommendations by professional bodies. Personal and professional competence is necessary to provide safe and effective genetic counselling. Clinical and counselling supervision of genetics healthcare practitioners plays a key role in quality assurance, providing a safe environment not only for patients but for professionals too. However, in many European countries, genetic counsellors are still an emerging professional group and counselling supervision is not routinely offered and there are no enough evidences on the impact of these insufficiencies. This study aimed to explore the current status of genetic counselling supervision provision across Europe and to ascertain factors that might be relevant for the successful implementation of counselling supervision. A total of 100 practitioners responded to an online survey; respondents were from 18 countries, with the majority working in France (27%) and Spain (17%). Only 34 participants reported having access to genetic counselling supervision. Country of origin, the existence of a regulation system and years of experience were factors identified as relevant, influencing access and characteristics of counselling supervision. Although there is a growing number of genetic counsellors trained at European level, just a few countries have implemented and required as mandatory the access to genetic counselling supervision. Nevertheless, this is essential to ensure a safe and effective genetic counselling and should be regulated at the European genetic healthcare services.
Collapse
Affiliation(s)
- Milena Paneque
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; CGPP - Centro de Genética Preditiva e Preventiva, IBMC - Instituto de Biologia Molecular e Celular, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
| | - Lídia Guimarães
- Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; AAJUDE - Associação de Apoio à Juventude Deficiente, Portugal
| | | | - Sara Pasalodos
- Department of Medical Genetics, Complejo Hospitalario de Navarra, Universidad Publica de Navarra (UPNA), Navarra-biomed-IdiSNA (Navarra Institute for Health Research), Pamplona, Navarra, Spain
| | | | - Irene Esteban
- Clinical Genetics Department, Queen Elizabeth University Hospital. Glasgow, Scotland, United Kingdom
| | - Carolina Lemos
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
| | - Ramona Moldovan
- Department of Psychology, Babeş-Bolyai University, Romania; Division of Evolution and Genomic Sciences, University of Manchester, United Kingdom, Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, UK
| | - Clara Serra-Juhé
- Genetics Department, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, 08041, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Spain
| |
Collapse
|
10
|
Hurtado-de-Mendoza A, Reyna VF, Wolfe CR, Gómez-Trillos S, Sutton AL, Brennan A, Sheppard VB. Adapting a Theoretically-Based intervention for underserved clinical populations at increased risk for hereditary Cancer: Lessons learned from the BRCA-Gist experience. Prev Med Rep 2022; 28:101887. [PMID: 35855922 PMCID: PMC9287635 DOI: 10.1016/j.pmedr.2022.101887] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Revised: 06/04/2022] [Accepted: 07/01/2022] [Indexed: 11/15/2022] Open
Abstract
The use of GCT in underserved diverse populations is suboptimal. Translational genomics research has been conducted with mostly NHW. Adapting EBIs can enhance the reach of EBI to underserved diverse populations. This paper describes the adaptation BRCA Gist, for at-risk Blacks and Latinas. Findings illustrate the need to integrate fidelity and adaptation considerations.
Background Minorities at increased risk for Hereditary Breast and Ovarian Cancer (HBOC) frequently have low awareness and use of genetic counseling and testing (GCT). Making sure that evidence-based interventions (EBIs) reach minorities is key to reduce disparities. BRCA-Gist is a theory-informed EBI that has been proven to be efficacious in mostly non-Hispanic White non-clinical populations. We conducted formative work to inform adaptations of BRCA-Gist for use in clinical settings with at-risk diverse women. Methods Genetic counselors (n = 20) were recruited nationally; at-risk Latinas and Blacks (n = 21) were recruited in Washington DC and Virginia. They completed the BRCA-Gist EBI between April 2018 – September 2019. Participants completed an acceptability scale and an interview to provide suggestions about implementation adaptations. T-tests for independent samples compared acceptability between at-risk women and genetic counselors. The Consensual Qualitative Research Framework was used to code adaptation suggestions. Suggested adaptations were discussed by a multidisciplinary team to integrate fidelity and adaptation considerations. Results At-risk women had a significantly higher acceptability (M = 4.17, SD = 0.47 vs. M = 3.24, SD = 0.64; p = 0.000; scale 1–5) and satisfaction scores (M = 8.3, SD = 1.3 vs. M = 4.2, SD = 2.0; p = 0.000; scale 1–10) than genetic counselors. Genetic counselors and at-risk women suggested contextual (e.g. format) and content (e.g. shortening) adaptations to enhance the fit of BRCA-Gist for diverse clinical populations. Conclusions Findings illustrate the process of integrating fidelity and adaptation considerations to ensure that EBIs retain their core components while enhancing the fit to minoritized clinical populations. Future studies will test the efficacy of the adapted BRCA-Gist in a Randomized Controlled Trial.
Collapse
Affiliation(s)
- Alejandra Hurtado-de-Mendoza
- Department of Oncology, Georgetown University Medical Center, Washington, DC, USA.,Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics, Washington, DC, USA
| | - Valerie F Reyna
- Human Neuroscience Institute, Cornell University, Ithaca, NY, USA
| | | | - Sara Gómez-Trillos
- Department of Oncology, Georgetown University Medical Center, Washington, DC, USA.,Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics, Washington, DC, USA
| | - Arnethea L Sutton
- Department of Health Behavior Policy, Virginia Commonwealth University, VA, USA
| | - Ashleigh Brennan
- Department of Oncology, Georgetown University Medical Center, Washington, DC, USA
| | - Vanessa B Sheppard
- Department of Health Behavior Policy, Virginia Commonwealth University, VA, USA
| |
Collapse
|
11
|
Cohen Kfir N, Rudolf M, Bentwich ME, Dickman N, Falik-Zaccai TC. 'LEADERS': A culturally tailored approach to genetic counseling for minority populations. J Genet Couns 2021; 30:70-74. [PMID: 33403704 DOI: 10.1002/jgc4.1369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 11/12/2020] [Accepted: 11/23/2020] [Indexed: 11/09/2022]
Affiliation(s)
- Nehama Cohen Kfir
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.,Institute of Human Genetics, Galilee Medical Center, Nahariya, Israel
| | - Mary Rudolf
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel
| | | | - Nomy Dickman
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel
| | - Tzipora C Falik-Zaccai
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.,Institute of Human Genetics, Galilee Medical Center, Nahariya, Israel
| |
Collapse
|
12
|
Nazareth S, Nussbaum RL, Siglen E, Wicklund CA. Chatbots & artificial intelligence to scale genetic information delivery. J Genet Couns 2020; 30:7-10. [PMID: 33191601 DOI: 10.1002/jgc4.1359] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Revised: 09/08/2020] [Accepted: 10/09/2020] [Indexed: 01/08/2023]
Affiliation(s)
| | | | - Elen Siglen
- Western Norway Familial Cancer Center, Haukeland University Hospital, Bergen, Norway
| | | |
Collapse
|
13
|
Pichler T, Rohrmoser A, Letsch A, Westphalen CB, Keilholz U, Heinemann V, Lamping M, Jost PJ, Riedmann K, Herschbach P, Goerling U. Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine? Support Care Cancer 2020; 29:2171-2178. [PMID: 32885314 PMCID: PMC7892511 DOI: 10.1007/s00520-020-05692-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Accepted: 08/19/2020] [Indexed: 01/05/2023]
Abstract
Purpose Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and communication. To meet these challenges, healthcare professionals need to gain deeper insight into patients’ subjective experiences. Therefore, this qualitative study examined information aspects of MD programs in cancer patients. Methods In two German Comprehensive Cancer Centers, 30 cancer patients undergoing MD participated in semi-structured interviews on information transfer and information needs regarding MD. Additionally, patients provided sociodemographic and medical data and indicated their subjective level of information (visual analogue scale, VAS, 0–10). Results On average patients had high levels of information (mean = 7, median = 8); nevertheless 20% (n = 6) showed an information level below 5 points. Qualitative analysis revealed that patients show limited understanding of the complex background of MD and have uncertainties regarding their personal benefit. Further, patients described unmet information needs. Existential threat in awaiting the results was experienced as burdensome. To withstand the strains of their situation, patients emphasized the importance of trusting their physician. Conclusion The challenges in PCM consist in providing unambiguous information, especially concerning treatment benefit, and providing guidance and support. Therefore, psycho-oncology needs to develop guidelines for adequate patient communication in order to help healthcare providers and cancer patients to handle these challenges in the developing field of PCM. Electronic supplementary material The online version of this article (10.1007/s00520-020-05692-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Theresia Pichler
- Comprehensive Cancer Center Munich, partner site TUM, Klinikum rechts der Isar, Munich, Germany. .,Comprehensive Cancer Center Munich, partner site LMU, University hospital, LMU Munich, Munich, Germany.
| | - Amy Rohrmoser
- Charité - Universitätsmedizin Berlin, Charité Comprehensive Cancer Center, Berlin, Germany
| | - Anne Letsch
- Charité - Universitätsmedizin Berlin, Charité Comprehensive Cancer Center, Berlin, Germany.,Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
| | - C Benedikt Westphalen
- Comprehensive Cancer Center Munich, partner site LMU, University hospital, LMU Munich, Munich, Germany.,Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
| | - Ulrich Keilholz
- Charité - Universitätsmedizin Berlin, Charité Comprehensive Cancer Center, Berlin, Germany
| | - Volker Heinemann
- Comprehensive Cancer Center Munich, partner site LMU, University hospital, LMU Munich, Munich, Germany.,Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
| | - Mario Lamping
- Charité - Universitätsmedizin Berlin, Charité Comprehensive Cancer Center, Berlin, Germany.,Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
| | - Philipp J Jost
- Center for Personalized Oncology (ZPO), Comprehensive Cancer Center Munich, partner site TUM, Munich, Germany.,Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, TUM, Munich, Germany
| | - Kristina Riedmann
- Center for Personalized Oncology (ZPO), Comprehensive Cancer Center Munich, partner site TUM, Munich, Germany.,Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, TUM, Munich, Germany
| | | | - Ute Goerling
- Charité - Universitätsmedizin Berlin, Charité Comprehensive Cancer Center, Berlin, Germany
| |
Collapse
|
14
|
Parent of Origin Effects on Family Communication of Risk in BRCA+ Women: A Qualitative Investigation of Human Factors in Cascade Screening. Cancers (Basel) 2020; 12:cancers12082316. [PMID: 32824510 PMCID: PMC7464326 DOI: 10.3390/cancers12082316] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 08/08/2020] [Accepted: 08/13/2020] [Indexed: 12/22/2022] Open
Abstract
Pathogenic germline variants in Breast Cancer 1/2 (BRCA) genes confer increased cancer risk. Understanding BRCA status/risk can enable family cascade screening and improve cancer outcomes. However, more than half of the families do not communicate family cancer history/BRCA status, and cancer outcomes differ according to parent of origin (i.e., maternally vs. paternally inherited pathogenic variant). We aimed to explore communication patterns around family cancer history/BRCA risk according to parent of origin. We analyzed qualitative interviews (n = 97) using template analysis and employed the Theory of Planned Behavior (TPB) to identify interventions to improve communication. Interviews revealed sub-codes of ‘male stoicism and ‘paternal guilt’ that impede family communication (template code: gender scripting). Conversely, ‘fatherly protection’ and ‘female camaraderie’ promote communication of risk. The template code ‘dysfunctional family communication’ was contextualized by several sub-codes (‘harmful negligence’, ‘intra-family ignorance’ and ‘active withdrawal of support’) emerging from interview data. Sub-codes ‘medical misconceptions’ and ‘medical minimizing’ deepened our understanding of the template code ‘medical biases’. Importantly, sub-codes of ‘informed physicians’ and ‘trust in healthcare’ mitigated bias. Mapping findings to the TPB identified variables to tailor interventions aimed at enhancing family communication of risk and promoting cascade screening. In conclusion, these data provide empirical evidence of the human factors impeding communication of family BRCA risk. Tailored, theory-informed interventions merit consideration for overcoming blocked communication and improving cascade screening uptake.
Collapse
|
15
|
Putt S, Yanes T, Meiser B, Kaur R, Fullerton JM, Barlow-Stewart K, Schofield PR, Toma C, Peay H, Mitchell PB. Exploration of experiences with and understanding of polygenic risk scores for bipolar disorder. J Affect Disord 2020; 265:342-350. [PMID: 32090758 DOI: 10.1016/j.jad.2020.01.037] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2019] [Revised: 11/27/2019] [Accepted: 01/11/2020] [Indexed: 01/04/2023]
Abstract
BACKGROUND Polygenic risk scores (PRSs) summarise genetic risk in complex genetic disorders such as bipolar disorder (BD). The aim of this study was to gain in-depth, nuanced information regarding the understanding and experience of receiving a PRS for BD from individuals who already have a BD diagnosis. METHODS Participants from a previous genetics study were invited to receive their PRS in a face-to-face consultation with a genetic counsellor or psychiatrist. Four weeks later, semi-structured interviews were conducted, with 14 'acceptors' (those who chose to receive their PRS) and 4 'decliners' (those who did not wish to receive their PRS). RESULTS Four themes were developed: (1) An easy decision, (2) A positive experience, (3) The grey area, and (4) The future is exciting and frightening. Despite some reported initial shock and distress, all acceptors described the experience of receiving their PRS as a positive one. It allowed them to better understand their condition and/or reduced feelings of self-blame. Decliners chose not to receive their results because of a lack of perceived usefulness or concern that PRS may hinder personal recovery. LIMITATIONS Given the qualitative design of the study, statistically valid generalisations cannot be undertaken, nor can causal relationships be established. CONCLUSIONS PRS for BD were generally well accepted and understood. Knowledge regarding the impact of PRS for BD ensures that counselling frameworks are responsive to patient needs as well as informing education for psychiatrists and genetic counsellors, who will play pivotal roles in future polygenic testing provision.
Collapse
Affiliation(s)
- Sophie Putt
- University of New South Wales Medicine, Sydney, NSW 2052, Australia.
| | - Tatiane Yanes
- Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia
| | - Bettina Meiser
- Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia
| | - Rajneesh Kaur
- Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia
| | - Janice M Fullerton
- Neuroscience Research Australia, Randwick, Sydney, NSW 2031, Australia; School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia
| | - Kristine Barlow-Stewart
- Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2000, Australia
| | - Peter R Schofield
- Neuroscience Research Australia, Randwick, Sydney, NSW 2031, Australia; School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia
| | - Claudio Toma
- Neuroscience Research Australia, Randwick, Sydney, NSW 2031, Australia; School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia
| | - Holly Peay
- National Human Genome Research Institute, Bethesda, United States
| | - Philip B Mitchell
- School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia; Black Dog Institute, Prince of Wales Hospital, Sydney, NSW 2052, Australia
| |
Collapse
|
16
|
Biesecker B. Genetic Counseling and the Central Tenets of Practice. Cold Spring Harb Perspect Med 2020; 10:cshperspect.a038968. [PMID: 31570379 DOI: 10.1101/cshperspect.a038968] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Genetic counseling is a profession growing and evolving at an extraordinary rate. This growth is driven by an explosion in what we know, as a result of progress in science, technology, and bioinformatics, and an explosion in what we do not know, as we strive to understand the impact of genomic information on the lives of our patients and clients. Genetic counselors work in an increasing number of subspecialties and diversity of settings. But although the field has evolved, it has maintained a remarkably unchanged core of shared values and beliefs. The heart of genetic counseling practice is the therapeutic relationship, with its dual role of providing information and facilitating assimilation of that information to personalize health-related decision-making and foster successful adaptation. Genetic counseling aims to communicate cutting-edge genomic science within an empathic understanding of the client/patient's concerns and needs. In pursuit of these goals, further assessment of genetic counseling's effectiveness is needed to facilitate evidence-based practices and to scale counseling resources.
Collapse
|
17
|
Bartley N, Best M, Jacobs C, Juraskova I, Newson AJ, Savard J, Meiser B, Ballinger ML, Thomas DM, Biesecker B, Butow P. Cancer patients' views and understanding of genome sequencing: a qualitative study. J Med Genet 2020; 57:671-676. [PMID: 31980566 DOI: 10.1136/jmedgenet-2019-106410] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2019] [Revised: 12/03/2019] [Accepted: 12/22/2019] [Indexed: 12/24/2022]
Abstract
BACKGROUND Little is known about knowledge of, and attitudes towards, genome sequencing (GS) among individuals with a personal history of cancer who decide to undergo GS. This qualitative study aimed to investigate baseline knowledge and attitudes among individuals previously diagnosed with a cancer of likely genetic origin who have consented to GS. METHODS Semistructured interviews were conducted with purposively selected participants (n=20) from the longitudinal Psychosocial Issues in Genomic Oncology study, within a month of consenting to GS and prior to receiving any results. Participants were adults with a cancer of likely genetic aetiology who are undertaking GS as part of a larger genetic study. RESULTS Analysis identified three main themes: limited understanding of genomics; multifactorial motivation; and complex decision making. While motivations such as obtaining health information about self and family appear to be the main drivers for undertaking GS, these motivations are sometimes based on limited knowledge of the accuracy and utility of GS, creating unrealistic expectations. This in turn can prolong the deliberation process and lead to ongoing decisional conflict. CONCLUSION Understanding the degree and nature of patient understanding of GS, as well as their attitudes and decision-making processes, will enable healthcare professionals to better manage patient expectations and appropriately engage and support patients to make an informed decision when pursuing GS.
Collapse
Affiliation(s)
- Nicci Bartley
- School of Psychology, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia
| | - Megan Best
- School of Psychology, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia
| | - Chris Jacobs
- Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia
| | - Ilona Juraskova
- School of Psychology, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia
| | - Ainsley J Newson
- School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
| | - Jacqueline Savard
- School of Medicine, Faculty of Health, Deakin University, Burwood, Victoria, Australia
| | - Bettina Meiser
- Prince of Wales Clinical School, University of New South Wales Sydney, Sydney, New South Wales, Australia
| | - Mandy L Ballinger
- The Kinghorn Cancer Center and Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
| | - David M Thomas
- The Kinghorn Cancer Center and Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
| | - Barbara Biesecker
- Research Triangle Institute, Research Triangle Park, North Carolina, USA
| | - Phyllis Butow
- School of Psychology, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia
| |
Collapse
|
18
|
Benjamin C, Phillips A, Finch J, Dubois L, McGrath L, Kulke C, Brooks C, Harris P, Daly J, Birch J, Nickson K. Exploring professional issues: the psychosocial component of genetic counseling in genomic healthcare. Per Med 2020; 17:55-65. [DOI: 10.2217/pme-2019-0048] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Aim: To determine UK genetic counselors’ (UKGCs) opinion regarding ‘the psychosocial component of the UKGC remit in the new genomics era’. Methods: Facilitated discussions at a national conference (2016) using interactive methodologies (58 participants). Results: UKGCs recognized the rapid rate of change emerging with advances in genomic science. Change will be required to the UKGC remit and the roles, rules, relationships and responsibilities that underpin it (29 topics identified). UKGCs supported their ‘unique selling point’; integrating knowledge and the explicit focus on psychosocial aspects of genomic healthcare. By 2019, some of the aspirations have been achieved. Conclusion: UKGCs should proactively position themselves to capitalize on the challenges and opportunities of genomic healthcare to maximize patient benefit.
Collapse
Affiliation(s)
- Caroline Benjamin
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | | | - Julia Finch
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Louise Dubois
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Lisa McGrath
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Claire Kulke
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Claire Brooks
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Pam Harris
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Janette Daly
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Jan Birch
- Liverpool Centre for Genomic Medicine, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK
| | - Katie Nickson
- Academic Unit of Medical Genetics & Pathology, University of Glasgow, Glasgow, Scotland, UK
| |
Collapse
|
19
|
Best MC, Bartley N, Jacobs C, Juraskova I, Goldstein D, Newson AJ, Savard J, Meiser B, Ballinger M, Napier C, Thomas D, Biesecker B, Butow P. Patient perspectives on molecular tumor profiling: "Why wouldn't you?". BMC Cancer 2019; 19:753. [PMID: 31366375 PMCID: PMC6670204 DOI: 10.1186/s12885-019-5920-x] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2019] [Accepted: 07/10/2019] [Indexed: 12/28/2022] Open
Abstract
Aim This study explored the attitudes of patients with advanced cancer towards MTP and return of results, prior to undergoing genomic testing within a research program. Methods Participants were recruited as part of the longitudinal PiGeOn (Psychosocial Issues in Genomics in Oncology) study involving patients with advanced/metastatic solid cancer who had exhausted therapeutic options and who were offered MTP in order to identify cognate therapies. Twenty patients, selected by purposive sampling, were interviewed around the time they gave consent to MTP. Interviews were audio recorded, transcribed and analysed using thematic analysis. Themes identified in the transcripts were cross-validated via qualitative responses to the PiGeOn study survey (n = 569; 63%). Results All interviewed participants gave consent to MTP without reservation. Three themes were identified and further supported via the survey responses: (1) Obvious agreement to participate, primarily because of desire for new treatments and altruism. (2) The black box – while participant knowledge of genomics was generally poor, faith in their oncologists and the scientific process encouraged them to proceed with testing; and (3) Survival is the priority – receiving treatment to prolong life was the priority for all participants, and other issues such as identification of a germline variant were generally seen as ancillary. Conclusion Having advanced cancer seemed to abrogate any potential concerns about MTP. Participants valued the research for varied reasons, but this was secondary to their priority to survive. While no negative attitudes toward MTP emerged, limitations in understanding of genomics were evident. Electronic supplementary material The online version of this article (10.1186/s12885-019-5920-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Megan C Best
- University of Sydney, School of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), Level 6 North, Lifehouse C39Z, Sydney NSW, Sydney, 2006, Australia.
| | - Nicole Bartley
- University of Sydney, School of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), Level 6 North, Lifehouse C39Z, Sydney NSW, Sydney, 2006, Australia
| | - Chris Jacobs
- University of Technology Sydney, Graduate School of Health, Broadway NSW, Sydney, 2007, Australia
| | - Ilona Juraskova
- University of Sydney, School of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), Level 6 North, Lifehouse C39Z, Sydney NSW, Sydney, 2006, Australia
| | - David Goldstein
- Prince of Wales Clinical School, University of NSW, High Street, Kensington, NSW, 2032, Australia
| | - Ainsley J Newson
- Faculty of Medicine and Health, Sydney Health Ethics, University of Sydney, 92/94 Parramatta Road, Camperdown, NSW, 2050, Australia
| | - Jacqueline Savard
- School of Medicine, Deakin University, 1 Gheringhap Street, Geelong, Victoria, 3220, Australia
| | - Bettina Meiser
- Psychosocial Research Group, Prince of Wales Clinical School, University of NSW, HighStreet, Kensington, NSW, 2032, Australia
| | - Mandy Ballinger
- Cancer Division, Garvan Institute of Medical Research, 384 Victoria street, Darlinghurst, NSW, 2010, Australia
| | - Christine Napier
- Cancer Division, Garvan Institute of Medical Research, 384 Victoria street, Darlinghurst, NSW, 2010, Australia
| | - David Thomas
- Cancer Division, Garvan Institute of Medical Research, 384 Victoria street, Darlinghurst, NSW, 2010, Australia
| | | | - Phyllis Butow
- University of Sydney, School of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), Level 6 North, Lifehouse C39Z, Sydney NSW, Sydney, 2006, Australia
| | | |
Collapse
|
20
|
|
21
|
Joseph G, Lee R, Pasick RJ, Guerra C, Schillinger D, Rubin S. Effective communication in the era of precision medicine: A pilot intervention with low health literacy patients to improve genetic counseling communication. Eur J Med Genet 2018; 62:357-367. [PMID: 30553023 DOI: 10.1016/j.ejmg.2018.12.004] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Revised: 12/05/2018] [Accepted: 12/08/2018] [Indexed: 01/19/2023]
Abstract
Effective communication, where all parties share a common understanding, is necessary to realize the promise of Genomic Medicine. It is especially salient given the imperative to increase the participation of diverse populations in genomics research and to expand the reach of clinical genomics. We have previously shown that cancer genetic counseling is suboptimal for patients with limited health literacy. To address this finding, we implemented a pilot study to improve verbal communication between genetic counselors and their patients of limited health literacy that consisted of: i) curriculum development and delivery of a Genetic Counselors (GC) communication workshop; ii) two-month post-workshop interviews with GC participants (n = 9); iii) observations/audio recordings of counseling sessions involving 24 patients and two GC workshop participants; iv) post-counseling interviews with patients (n = 9). The 4.5-h workshop presented evidenced-based principles and strategies for effective communication with limited health literacy patients (e.g. use of plain language and teach-back), and offered specific techniques and exercises to practice adoption of such practices in the genetic counseling context. GCs expressed appreciation for the opportunity to refine their skills; however, they reported that some strategies were challenging given their professional training and communication habits. For example, GCs were concerned that use of plain language could undermine efforts to obtain informed consent and provide scientifically accurate information. Observations and patient interviews after the workshop revealed that GCs were able to employ the communication strategies with positive effects, with patients indicating sufficient understanding of the genetic test and its implications as well as satisfaction with the counselors' communication. While derived from research on communication with those of limited health literacy, the communication approaches taught in the GC workshop could benefit most patients, given the high rates of low health literacy in many countries, and the many factors beyond health literacy that can contribute to reduced comprehension in health care environments.
Collapse
Affiliation(s)
- Galen Joseph
- Department of Anthropology, History & Social Medicine, University of California, San Francisco, United States; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, United States.
| | - Robin Lee
- Cancer Genetics & Prevention Program, University of California, San Francisco, United States
| | - Rena J Pasick
- Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, United States; Department of General Internal Medicine, University of California, San Francisco, United States
| | - Claudia Guerra
- Department of General Internal Medicine, University of California, San Francisco, United States
| | - Dean Schillinger
- Department of Medicine, University of California, San Francisco, United States
| | - Sara Rubin
- Department of Social & Behavioral Sciences, University of California, San Francisco, United States
| |
Collapse
|
22
|
Wicklund CAL, Duquette DA, Swanson AL. Clinical genetic counselors: An asset in the era of precision medicine. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS 2018; 178:63-67. [DOI: 10.1002/ajmg.c.31605] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2018] [Revised: 02/15/2018] [Accepted: 02/16/2018] [Indexed: 01/01/2023]
Affiliation(s)
- Catherine A. L. Wicklund
- Graduate Program in Genetic Counseling, Department of Obstetrics and GynecologyNorthwestern University Feinberg School of MedicineChicago Illinois
| | - Debra A. Duquette
- Graduate Program in Genetic Counseling, Department of CardiologyNorthwestern University Feinberg School of MedicineChicago Illinois
| | - Amy L. Swanson
- Graduate Program in Genetic Counseling, Department of Obstetrics and GynecologyNorthwestern University Feinberg School of MedicineChicago Illinois
| |
Collapse
|
23
|
Djurdjinovic L, Peters JA. Special Issue Introduction: Dealing with Psychological and Social Complexity in Genetic Counseling. J Genet Couns 2017; 26:1-4. [PMID: 28271394 DOI: 10.1007/s10897-017-0080-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Accepted: 02/06/2017] [Indexed: 10/20/2022]
Affiliation(s)
| | - June A Peters
- Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 9609 Medical Center Drive, # 6E548, Rockville, MD, 20850, USA
| |
Collapse
|
24
|
Biesecker B, Austin J, Caleshu C. Response to A Different Vantage Point Commentary: Psychotherapeutic Genetic Counseling, Is it? J Genet Couns 2016; 26:334-336. [PMID: 27804046 DOI: 10.1007/s10897-016-0025-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2016] [Accepted: 09/12/2016] [Indexed: 11/30/2022]
Abstract
Whether genetic counseling is a form of psychotherapy is open for debate. Early practicioners in genetic counseling described it as such, and this claim has been replicated in recent publications. This commentary is a rebuttal to the claim that genetic counseling is distinct from psychotherapty. We argue that it is a a form of psychoterapy that aims to help clients manage a health threat that affects their psychological wellbeing, paralleling the goals of psychotherapy.
Collapse
Affiliation(s)
- Barbara Biesecker
- National Human Genome Research Institute, National Institutes of Health, Maryland, Bethesda, MD, 20897-2073, USA.
| | | | | |
Collapse
|